Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized Trial: Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)

NCT07554573 is registered in ClinicalTrials.gov with NRG Oncology as lead sponsor.

NCT NCT07554573
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07554573 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized Trial: Assessment of Biosignature Classification of DCIS for RadioTherapy Benefit Post Lumpectomy (ABCD RT)
Lead sponsor
NRG Oncology
Phase
Phase 3
Overall status
Not yet recruiting
Start date
January 30, 2027
Completion date
July 31, 2048
Enrollment
5,270 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer